If You Already Have Lyme Disease and Get Bit Again Does It Activate Faster/
In the autumn of 1997, after I graduated from higher, I began experiencing what I called "electric shocks"—tiny stabbing sensations that flickered over my legs and artillery every morning. They were and then extreme that as I walked to piece of work from my East Village basement apartment, I ofttimes had to end on 9th Street and rub my legs against a parking meter, or else my muscles would brainstorm twitching and spasming. My physician couldn't figure out what was wrong—dry skin, he proposed—and somewhen the shocks went away. A yr subsequently, they returned for a few months, only to go away again but when I couldn't bear information technology anymore.
Over the years, the shocks and other strange symptoms—vertigo, fatigue, joint hurting, memory problems, tremors—came and went. In 2002, I began waking up every night drenched in sweat, with hives covering my legs. A doctor I consulted thought, based on a examination result, that I might have lupus, simply I had few other markers of the autoimmune disease. In 2008, when I was 32, doctors identified arthritis in my hips and cervix, for which I had surgery and concrete therapy. I was too bizarrely exhausted. Nothing was really wrong, the doctors I visited told me; my tests looked fine.
In 2012, I was diagnosed with a relatively balmy autoimmune affliction, Hashimoto's thyroiditis. All the same despite eating carefully and sleeping well, I was having difficulty performance, which didn't make sense to my medico—or to me. Recalling basic words was often challenging. Education a poetry form at Princeton, I found myself talking to the students about "the season that comes after wintertime, when flowers grow." I was in nearly-constant pain, as I wrote in an essay for The New Yorker at the time near living with chronic illness. Nonetheless some part of me thought that peradventure this was what everyone in her mid-30s felt. Pain, exhaustion, a leaden mind.
I chilly December night in 2012, I collection a few colleagues back to Brooklyn subsequently our department holiday party in New Jersey. I looked over at the man sitting adjacent to me—a novelist I'd known for years—and realized that I had no thought who he was. I pondered the problem. I knew I knew him, but who was he? It took an 60 minutes to recover the information that he was a friend. At home, I asked my partner, Jim, whether he had always experienced anything like this. He shook his head. Something was wrong.
By the following fall, any outing—to teach my grade, or to attend a friend'southward birthday dinner—could mean days in bed afterward. I hid matters as best I could. Debt piled upwards as I sought out top-tier physicians (many of whom didn't take insurance)—a neurologist who diagnosed neuropathy of unclear origin, a rheumatologist who diagnosed "unspecified connective-tissue disease" and gave me steroids and intravenous immunoglobulin infusions. I visited acupuncturists and nutritionists. I saw expensive out-of-network "integrative" doctors (1000.D.due south who have a holistic approach to wellness) and was diagnosed with overexhaustion and given Iv vitamin drips. Many doctors, I could tell, weren't certain what to remember. Is this all in her head? I felt them wondering. One suggested I see a therapist. "Nosotros're all tired," some other chided me.
I was a patient of relative privilege who had access to excellent medical care. Notwithstanding, I felt terrifyingly lonely—until, in the fall of 2013, I found my manner to still another doctor, who had an interest in infectious diseases, and tested me for Lyme. I had grown up on the East Coast, camping and hiking. Over the years, I had pulled many engorged deer ticks off myself. I'd never gotten the archetype balderdash'southward-center rash, just this doctor ordered several Lyme-disease tests anyway; though indeterminate, the results led her to think I might have the infection.
Explore the September 2022 Issue
Check out more from this issue and find your next story to read.
I began to practice research, and discovered other patients like me, with troubling joint pain and neurological problems. To go along symptoms at bay, some of them had been taking oral and intravenous antibiotics for years, which tin can be unsafe; one acquaintance of mine was on her fifth or sixth course of IV drugs, considering that was the only handling she'd found that kept her cognitive faculties functioning. I read posts by people who experienced debilitating exhaustion and retentivity impairment. Some were so disoriented that they had trouble finding their ain home. Others were severely depressed. Along the way, near all had navigated a medical organisation that had discredited their testimony and struggled to give them a diagnosis. Many had been shunted past internists to psychiatrists. The stories were not encouraging.
After a decade and a one-half in the dark, I at last had a possible name for my problems. Yet instead of feeling relief, I felt I had woken into a nightmare. I wasn't sure whether the illness I had really was untreated Lyme. Even if I did take Lyme, there was little agreement about how to treat a patient similar me—whose examination results were equivocal and who had been diagnosed very late in the course of the disease—and no guarantee that I would get better if I tried antibiotics.
It was a scary path to walk down. My own dr. cautioned that the label Lyme disease was easy to pin on one's symptoms, because the tests can be inaccurate. I understood. I'd gotten my hopes up before. My experience of medicine had led me to conclude that specialists oftentimes saw my troubles through their particular lens—an autoimmune affliction! a viral event! your mind! And I worried that if I were to go run into a Lyme specialist—an internist with a focus on the affliction—he would say I had it no matter what.
In the absence of medical clarity, I had to decide what to do. Was I going to become a Lyme patient? If then, whom was I to trust, and how far would I go? Then one night, in my rabbit-hole searching, I stumbled on a thread of Lyme patients describing the same electric shocks that had bedeviled me for years. The back of my neck went common cold. For nearly 20 years I had tried to find a doctor who would recall the problem was something other than dry out skin. I had asked friends if they had whatever idea what I was talking about. No one e'er did. I had thought I was imagining information technology, or being oversensitive—or was somehow at fault. To see my ordeal described in familiar, torturous detail jolted me to attending.
I knew and so that I needed to learn more near the circuitous reality of Lyme disease and tackle the near-incommunicable task of sorting out what was understood and what wasn't. I didn't yet know that simply by exploring whether untreated Lyme affliction could be the crusade of my illness, I risked being labeled one of the "Lyme loonies"—patients who believed that a long-ago bite from a tick was the cause of their years of suffering. They'd been called that in a 2007 email sent past the plan officer overseeing Lyme grants at the National Institutes of Health. The now-infamous phrase betrayed but how fiercely contested the affliction is—"ane of the biggest controversies that medicine has seen," every bit John Aucott, a physician and the director of the Johns Hopkins Lyme Disease Clinical Enquiry Center, later described information technology to me.
Lyme Illness was discovered in Connecticut in the mid-1970s. Today it is a major, and growing, health threat, whose achieve extends well beyond its initial Eastward Coast locus. Reported cases increased almost fivefold from 1992 to 2017, and the Centers for Disease Control and Prevention estimates that annual incidences take risen to more than 300,000, and may even range above 400,000. Step into parks in coastal Maine or Paris, and you'll see ominous signs in black and red type warning of the presence of ticks causing Lyme disease. In the summertime in the eastern United States, many parents I know cover their children from head to toe—never mind the estrus—for a hike in the woods or a jaunt to a grassy playground. On a recent trip to my brother'due south new country firm in Vermont, a few weeks before his partner woke up ane morning with a dramatic bull's-middle rash, I chased my toddler sons effectually, spraying them and so often with tick repellent that they thought we were playing a special outdoor game.
By at present, merely about everyone knows someone who's been diagnosed with Lyme disease, and most of us know to look for the telltale rash (frequently described equally a bull's-eye, many Lyme rashes are solid-colored lesions) and to inquire for a prompt dose of antibiotics. For most of those who get swiftly diagnosed and treated, that volition be the end of the story. But lots of Americans accept also heard secondhand reports of people who stayed sick later on that form of antibiotics. And lots know of cases in which no rash appeared and a diagnosis came belatedly, when damage had already been wrought. Plenty of others, upon discovering an attached deer tick, have encountered doctors who balk at prescribing antibiotics to treat a possible Lyme infection, wary of overdiagnosis.
/media/img/posts/2019/08/map_layers_title-3/original.gif)
The caste of alarm and defoliation nearly such a long-standing public-health issue is extraordinary. The consequences tin can't be overestimated, at present that Lyme affliction has become an about "unparalleled threat to regular American life," as Bennett Nemser, a former Columbia University epidemiologist who manages the Cohen Lyme and Tickborne Disease Initiative at the Steven & Alexandra Cohen Foundation, characterized information technology to me. "Actually anyone—regardless of age, gender, political interest, affluence—tin can touch a piece of grass and get a tick on them."
Even as changes in the climate and in land use are causing a dramatic rise in Lyme and other tick-borne diseases, the American medical establishment remains entrenched in a struggle over who can exist said to have Lyme disease and whether it can get chronic—and if and then, why. The collision has impeded research that could help break the logjam and analyze how a wily bacterium, and the co-infections that can come with it, can affect human bodies. After 40 years in the public-wellness spotlight, Lyme affliction even so can't be prevented past a vaccine; eludes reliable testing; and continues to pit patients against doctors, and researchers against one another. When I got my inconclusive diagnosis, I knew better than to dream of a quick cure. But I didn't know how farthermost the roller coaster of dubiousness would exist.
Lyme Disease came into public view when an epidemic of what appeared to be rheumatoid arthritis began afflicting children in Lyme, Connecticut. A young rheumatologist at Yale named Allen Steere, who at present conducts research at Massachusetts General Hospital, in Boston, studied the children. In 1976 he named the mysterious affliction after its locale and described its master symptoms more than fully: a bull'due south-middle rash; fevers and aches; Bong'south palsy, or partial paralysis of the face, and other neurological issues; and rheumatological manifestations such as swelling of the knees. Later on much written report, Steere realized that the black-legged ticks that live on mice and deer (among other mammals) might be harboring a pathogen responsible for the outbreak. In 1981, the medical entomologist Willy Burgdorfer finally identified the bacterium that causes Lyme, and information technology was named after him: Borrelia burgdorferi.
B. burgdorferi is a corkscrew-shaped bacterium known as a spirochete that can burrow deep into its host's tissue, causing damage as it goes and, in laboratory conditions at least, morphing as needed from corkscrew to cystlike hulk to, potentially, slimy "biofilm" forms. Considering of this ability, researchers describe it as an "allowed evader." Once it hits the man bloodstream, it changes its outer surface to elude an immune response, then quickly moves from the blood into tissue, which poses problems for early on detection. (Difficult to find in the bloodstream and other body fluids, the B. burgdorferi spirochete is hard to culture, which is how bacterial infections are definitively diagnosed.) If it goes untreated, B. burgdorferi can make its way into fluid in the joints, into the spinal cord, and even into the brain and the middle, where it tin can cause the sometimes mortiferous Lyme carditis.
Past the mid-'90s, a mainstream consensus emerged that Lyme affliction was relatively easy to diagnose—thanks to the telltale rash and flulike symptoms—and to care for. Infectious diseases are the kind of articulate-cutting illness that our medical system generally excels at handling. Evidence indicated that the prescribed treatment protocol—a few weeks of oral antibiotics, typically doxycycline—would have care of most cases that were caught early on, while late-stage cases of Lyme illness might require intravenous antibiotics for upward to a month. That assessment, made by the Infectious Diseases Club of America, formed the ground of the IDSA's treatment guidelines from 2006 until recently. (In late June, a revised draft called for, amidst other things, a shorter course—10 days—of doxycycline for patients with early Lyme.)
Withal the picture on the footing looked far murkier. A significant percentage of people who had Lyme symptoms and afterward tested positive for the illness had never gotten the rash. Others had many characteristic symptoms just tested negative for the infection, and entered treatment anyway. Well-nigh startling, a portion of patients who had been promptly and conclusively diagnosed with Lyme disease and treated with the standard course of doxycycline didn't actually get better. When people from each of these groups failed to recover fully, they began referring to their condition as "chronic Lyme disease," believing in some cases that the bacterium was yet lurking deep in their bodies.
Frustrated with the medical system's seeming disability to assist them, patients emerged every bit an activist force, arguing that Lyme disease was harder to cure than the institution best-selling. Family physicians in Lyme-endemic areas, confronted with patients who weren't getting better, tried out other treatment protocols, including long-term oral and intravenous antibiotics, sometimes administered for months or years. They likewise started testing assiduously for tick-borne co-infections, which were appearing in some of the sickest patients. Many of these doctors rotated drugs in the hope of finding a more than effective regimen. Some patients responded well. Others didn't get better. In 1999, these doctors banded together to form the International Lyme and Associated Diseases Society. Highlighting the bug with Lyme-disease tests and citing early evidence that bacteria could persist in animals and humans with Lyme disease even later they'd been treated, ILADS proposed an alternative standard of care that divers the illness more broadly and allowed for more than extensive treatment.
But some prominent Lyme-illness researchers were skeptical that the infection could persist subsequently handling—that bacteria could remain in the trunk. They argued that many chronic Lyme-disease patients were beingness treated for an infection they no longer had, while others had never had Lyme disease in the beginning place simply had appropriated the diagnosis for symptoms that could easily take other causes. Chronic Lyme affliction, in the Infectious Diseases Guild of America'south view, was a pseudoscientific diagnosis—an ideology rather than a biological reality. Nether the sway of that credo, it contended, credulous patients were needlessly being treated with unsafe IV antibiotics by irresponsible physicians. (It didn't assistance when a Lyme patient in her 30s died from an IV-related infection.)
To make its case, the IDSA cited a scattering of studies indicating that long-term antibiotic handling of patients with ongoing symptoms was no more than effective than a placebo—proof, in its view, that the bacterium wasn't causing the symptoms. The IDSA too highlighted statistics suggesting that the usually cited chronic Lyme symptoms—ongoing fatigue, encephalon fog, joint pain—occurred no more than often in Lyme patients than in the full general population. In the press, experts in this camp implied that patients who believed they had been sick with Lyme disease for years were deluded or mentally sick.
The antagonism was "vehement and alienating for the patients," Brian Fallon, the managing director of the Lyme and Tick-Borne Diseases Research Eye at Columbia University Irving Medical Heart, told me. Hostilities continued to intensify, not but between patients and experts, only between customs doctors and academic doctors. In 2006, the IDSA guidelines for patients and physicians argued that "in many patients, posttreatment symptoms appear to be more related to the aches and pains of daily living rather than to either Lyme disease or a tick-borne co-infection." This message rang hollow for many. "Researchers were maxim, 'Your symptoms have cipher to do with Lyme. You have chronic fatigue syndrome, or fibromyalgia, or depression,' " Fallon told me. "And that didn't make sense to these patients, who were well until they got Lyme, and and then were ill."
By the time the doctor showtime floated the possibility, in 2013, that I might have Lyme, my headaches, brain fog, and joint hurting had gotten much worse, and tiny bruises had bloomed all over my legs and arms. I was so dizzy that I began fainting. A black ocean, it seemed, kept crashing over me, so that I couldn't catch my breath. I could no more touch the old delights of my life than a firefly could bear upon the world beyond the jar in which it had been caught.
When I returned to the physician'due south function two weeks later to go over the test results, I didn't know what I was in for. Imperfect diagnostics lie at the core of the whole fence over Lyme disease. Standard Lyme tests—structured in two tiers, to minimize faux positives—can't reliably identify an infection early or decide whether an infection has been eradicated. That's considering the tests are not looking for the "immune evader" itself—the B. burgdorferi spirochete—in your blood. Instead, they assess indirectly: They look for the antibodies (the small-scale proteins our bodies create to fight infection) produced in response to the bacteria. But antibody production takes fourth dimension, which ways early detection tin can be hard. And once produced, antibodies can last for years, which makes it difficult to run across whether an infection is resolved, or even whether a new ane has occurred. What'southward more than, antibodies to autoimmune and viral diseases can look like the ones the torso makes in response to Lyme.
For a thorough interpretive reading, some doctors volition send blood to several different labs, which can deliver results that don't e'er concord with ane some other. And the CDC—which recommends that simply a specific pattern of antibodies, agreed on by experts in 1994, be considered indicative of a positive test—suggests that, when needed, doctors should use their judgment to make what's called a "clinical diagnosis," based on symptoms and likelihood of exposure, forth with the lab tests.
I was dislocated. My physician showed me mixed results from three labs. 2 had a positive response on one part of the examination but not the other, while the third had a negative response on both parts. Because of my medical history as well equally particular findings on my tests, she concluded that I probably did accept Lyme disease. Simply she also noted that I had a few nasty viruses, including Epstein-Barr. In addition, the test may have been picking up on autoimmune antibodies, given my before diagnosis.
At the recommendation of a science-writer friend, I finally went to see Richard Horowitz, a doctor in upstate New York who specializes in Lyme disease and had earned a reputation as a bright diagnostician. Horowitz, who goes by "Dr. H" with many of his patients, is a practicing Buddhist, with bright-blueish optics and an air of brimming eagerness. He recently served as a fellow member of the Tick-Borne Affliction Working Group convened by the Department of Health and Homo Services, which in 2022 issued a report to Congress outlining problems with the diagnosis and handling of Lyme patients.
I told him that I wasn't sure I had Lyme disease. I had brought along a stack of lab results nearly half a pes tall—a paper trail that would scare off many doctors. He perused every page, request questions and making notes. Finally, he looked upward.
"Based on your labs, your symptoms, and your various results over the years, I highly suspect yous have Lyme," he said. "Run across these?"—he bent over a set of results from Stony Brook laboratory—"these bands are specific for Lyme."
In his waiting room, I had completed an elaborate questionnaire designed to unmarried out Lyme patients from a pool of patients with other illnesses that touch multiple biological systems. (It has since been empirically validated every bit a screening tool.) Now Dr. H did a physical exam and ordered a range of tests to dominion out farther thyroid problems, diabetes, and other possible causes of my symptoms. Considering I had night sweats and the awareness that I couldn't go plenty air into my lungs—a symptom known every bit "air hunger"—he proposed that I might have a co-infection of babesia, a malaria-similar parasite also transmitted by ticks. Curious, I told him that I had always thought of Lyme as a primarily arthritic disease, whereas I had many neurological and cerebral symptoms. He explained that B. burgdorferi is now known to come in different strains, which are thought to produce unlike kinds of disease.
"The funny thing is, I think yous're really a very stiff and healthy person, and that's why you did okay for so long," he continued. "Now your trunk needs help."
Dr. H prescribed a calendar month of doxycycline, and warned me about something I'd read online. When I began the antibiotic, I might at first feel worse: As the bacteria die, they release toxins that create what'south known as a Jarisch-Herxheimer reaction—a flulike response that Lyme patients commonly refer to as "herxing." But over time, he said, I should feel better. If not, nosotros were on the incorrect track.
Over dinner that night, back in Brooklyn, I told Jim that despite what Horowitz had urged, I wasn't sure I wanted to take the antibiotics. I didn't take a cutting-and-stale positive examination for Lyme, and I knew how damaging antibiotics are to the microbiome. "What do you really have to lose?" he asked, in atheism. "You're sick, you're suffering, and you've tried everything else."
The side by side forenoon, I took a dose of the doxycycline, along with Plaquenil, which is thought to help the antibiotics penetrate cells meliorate. I took another dose that night with dinner. I went to bed and woke up feeling like hell. My throat was sore and my head was foggy. My neck was a fiery rebar.
Two days subsequently, we went out to get luncheon. I was still groggy and unwell. It was a heavy, gray day, with low clouds. Returning dwelling house, I felt rain all over my bare arms. I told Jim we should bustle.
"Why?" he said.
"It's raining!"
"Information technology's not raining," he said. "It's just cloudy." I raised my easily to show him the raindrops. A dozen pips of cold popped along my arm. Just in that location was no pelting. As we walked home, cold drops rushed all over my torso, my skin crawling as if a foreign, fierce h2o were cleansing it.
Several days afterward, though, I felt excited to fly to a conference in Chicago, rather than exhausted by the prospect. For three more than weeks, I took the drugs and supplements Dr. H had prescribed. The doxycycline made me allergic to the sun. 1 tardily-spring morning, I forgot to put sunblock on my right hand earlier taking a walk with a friend, holding a java cup. Information technology was 9 o'clock and cloudy. Past the time I got home, my mitt felt tender. Over the next few days a second-degree burn developed, blistering into an open wound.
After a month of antibiotic treatment, I took the train back upward to Dr. H's office. On his questionnaire, I rated my symptoms as less astringent than I had a month before, just my total score still fell in the loftier range. Dr. H changed the protocol, adding an antimalarial drug. He was concerned well-nigh my continued nighttime sweats and air hunger.
When I started taking the new drugs, in June 2014, I was nearly equally sick as I had e'er been. I flew to Paris to teach at NYU's summer writing program. Within ii days of arriving, I could barely walk down the street. Violent electric shocks lacerated my skin, and patches of burning pain and numbness spread up my neck. I shook and shivered. The reaction lasted 5 days, during which panic mixed with the pain. How was I to know whether this was herxing and a positive reaction to the drugs as they killed bacteria and parasites, or a manifestation of the disease itself? Or were weeks of antibiotics themselves causing problems for me?
"I know you lot think you're doing the right affair," a concerned colleague said, "but aren't yous just making yourself sicker?"
On the sixth day, I was sitting on the couch in my rented apartment and the shocks were then violent, racing across my forearms and thighs and calves, that when I looked up at the alpine open windows, the dominicus streaming through them, it occurred to me that I could spring out of them and notice relief.
The next morning time I woke up to the same bright dominicus, feeling meliorate than I had in ages. Stunned by my energy, I went out for a run. I wasn't exactly racing down the sidewalk, but 40 minutes after, for the kickoff time in years, I had run 3 miles. As the weeks passed, I felt better and meliorate. My drenching night sweats vanished. The air hunger was gone. I had loads of energy. I took antibiotics for several more months, and each calendar month I had fewer symptoms. After eight months of treatment, Dr. H decided that I could terminate. It was the spring of 2015.
That fall I got pregnant, at the age of 39. At Dr. H's urging, I took antibiotics on and off during my pregnancy. In the summertime of 2016, I delivered a healthy baby boy.
Past the time I started treatment, the fact that Lyme disease causes ongoing symptoms in some patients could no longer be viewed as the product of their imaginations. A well-designed longitudinal written report by John Aucott at Johns Hopkins showed the presence of persistent brain fog, articulation pain, and related issues in approximately x pct of even an ideally treated population—patients who got the Lyme rash and took the recommended antibiotics. Other studies found these symptoms in up to 20 percent of patients. The condition, christened "mail-handling Lyme disease syndrome," or PTLDS, is now recognized by the CDC. (Of course, the term doesn't apply to patients like me, who never had a rash or a clearly positive test.) Withal, the condition is hotly contested, and enough of high-level people in the field—besides as the Infectious Diseases Lodge of America itself—still don't recognize it as an official diagnosis. Perhaps most important, crucial questions about the cause of ongoing symptoms remain unanswered, due in part to the decades-long standoff over whether and how the disease can become chronic. As Sue Visser, the CDC's acquaintance managing director for policy in the Division of Vector-Borne Diseases, acknowledges, "Many are very rightfully frustrated that it's been decades and we still don't have answers for some patients."
Recently, though, a host of new studies has freshly tackled a lot of those questions: Why practise Lyme symptoms persist in only some patients? What don't we know about the behavior of the B. burgdorferi bacteria that might help explain the variation in patients' responses to information technology?
At that place isn't much federal funding to report Lyme disease, and what at that place is often goes to research on prevention and transmission. (The NIH spends only $768 on each new confirmed case of Lyme, compared with $36,063 on each new case of hepatitis C.) Much of the money to investigate PTLDS has come from private foundations, including the Steven & Alexandra Cohen Foundation, the Global Lyme Alliance, and the Bay Area Lyme Foundation. The CDC and the NIH recently reached out to these groups, officials told me, spurred on in part past the 2022 Tick-Borne Illness Working Grouping study to Congress outlining major holes in the scientific understanding of Lyme disease.
In a conversation I had with him, Bennett Nemser of the Cohen Foundation laid out some of the hypotheses that are currently being explored. The complexity is daunting. A patient with ongoing symptoms may actually withal have a Lyme infection, and/or a lingering infection from some other tick-borne disease. Or the original infection might have caused systemic damage, leaving a patient with recurring symptoms such as nerve hurting and chronic inflammation. Or the Lyme infection might have triggered an autoimmune response, in which the immune system starts attacking the body'southward own tissues and organs. Or a patient might exist suffering from some combination of all iii, complicated by triggers that researchers have not yet identified.
One way or another, an intricate interplay of the infection and the immune system, new research suggests, is at work in patients who don't get amend. The immune response to the Lyme infection, it turns out, is "highly variable," John Aucott told me. For example, some research has suggested that ongoing symptoms are a result of an overactive immune response triggered by Lyme disease. Recently, though, a study co-authored past Aucott with scientists at Stanford found that, in patients who developed PTLDS, the Lyme bacteria had actually inhibited the immune response.
By at present, accumulating show suggests that in many mammals, Lyme bacteria can persist later on treatment with antibiotics—leading more than scientists to wonder if the bacteria tin do the aforementioned in humans. In 2012, a team led by the microbiologist Monica Embers of the Tulane National Primate Research Center constitute intact B. burgdorferi lingering for months in rhesus macaques subsequently treatment. Embers also reported that the macaques had varying immune responses to the infection, possibly explaining why active bacteria remained in some. The written report drew criticism from figures in the IDSA establishment; in their view it failed to prove that the bacteria remained biologically active. Merely Embers told me that this year, in their piece of work with mice, she and her team have managed the feat of culturing B. burgdorferi, showing that it was viable after a course of doxycycline. New studies looking into possible bacterial persistence in humans—conducted past the National Institute of Allergy and Infectious Diseases, function of the NIH—are under style.
Meanwhile, several researchers, including Ying Zhang at the Johns Hopkins Bloomberg School of Public Health, take proposed another explanation for how B. burgdorferi can remain after handling: the presence of what are called "persister bacteria," similar to those constitute in certain hard-to-treat staph infections but long thought non to be in Lyme. In the case of Lyme disease, persister bacteria are a subpopulation that enters a dormant state, allowing them to survive a normally lethal siege of antibiotics. These persister bacteria, Zhang's team found, caused severe symptoms in mice, and the electric current single-antibody Lyme protocols didn't eradicate them—which makes sense: Doxycycline functions not past straight killing leaner, but by inhibiting their replication. Thus information technology affects only actively dividing bacteria, not dormant ones, relying on a healthy immune system to dispatch any B. burgdorferi that remain.
The big effect, though, was that when Zhang's team treated the mice with a three-antibiotic cocktail, including a drug known to work on persistent staph infections, the mice cleared the persistent B. burgdorferi infection. "We now have not only a plausible caption but also a potential solution for patients who endure from persistent Lyme-disease symptoms despite standard unmarried-antibiotic treatment," Zhang said. Taking the next step, Kim Lewis at Northeastern University, who has had a distinguished career studying persister bacteria, is almost to conduct a study, in collaboration with Brian Fallon, looking at whether a chemical compound that specifically targets persister cells tin can aid patients with PTLDS.
Of course, fifty-fifty if active bacteria do remain in some Lyme patients, they may well not be the cause of the symptoms, as many in the IDSA accept long contended. Paul Auwaerter, the clinical director of infectious diseases at Johns Hopkins Schoolhouse of Medicine and a former president of the IDSA, points out that Lyme bacteria can go out behind DNA "debris" that may trigger ongoing "low-grade inflammatory responses." Lewis told me that the overarching question—"whether the pathogen is in that location and is slowly causing damage, or has already left the trunk and has wrecked the immune system"—has however to be settled, in his view. But, he said, "I'1000 optimistic that nosotros and others are going to notice a cure for PTLDS."
When my son was seven months old, my interlude of feeling energetic and generally symptom-complimentary abruptly ended. He was not a adept sleeper, and months of waking at night had worn me downwards. In early April 2017, we both got ill, and I didn't recover. My body ached. My brain got foggy. My primary-care physician noted that the Epstein-Barr virus was active in my organization again. Dr. H suggested that the Lyme infection had recurred, and that I needed another course of antibiotics, only I hesitated. I wasn't certain whether to believe that the Lyme infection could persist, and I attributed my ill health to an autoimmune flare or postviral fatigue. For months I stalled, but presently the electrical shocks were back, zapping my arms and legs, and life became a slog. I started antibiotics. Within five days, my energy returned and I felt almost completely well again. A month later, feeling better than I had in well-nigh 20 years, I got pregnant with my second son.
Could this recovery exist attributed to the placebo effect?, I wondered. If so, it was the only placebo that had e'er worked for me.
Meanwhile, my father, who lived in Connecticut, had begun to suffer drenching night sweats, fatigue, and aches and pains. His tests were negative for Lyme but suggestive of ehrlichiosis, another tick-borne infection, and his physician—in the center of Lyme country—decided to treat what seemed like a plausible culprit and its co-infection. My father was put on doxycycline for five months. He didn't improve, which surprised me, given that I had seen immediate results. Then one twenty-four hour period my brother found him at dwelling, on the verge of collapse, and took him to an ER, where batteries of tests revealed that he had a different problem. He was suffering from Stage four Hodgkin's lymphoma.
In 2018, my father died of complications from pneumonia, after recovering from the cancer. I couldn't help wondering how much those lost months had peradventure cost him, as the cancer advanced and weakened him—all because Lyme had seemed like an obvious enough explanation, and the testing was sufficiently murky, that his doctor did non pursue other diagnoses. Though promising new diagnostic technologies are on the horizon, we nevertheless can't reliably sort out who has a tick-borne disease and who doesn't.
On a brisk March day this year, the kind of mean solar day that tin can't decide whether it's warm or common cold, I visited a research laboratory at Massachusetts Full general Hospital directed by Allen Steere, the rheumatologist who discovered Lyme disease and helped plant the testing parameters for information technology. A slim, grey-haired human being with an intense gaze, he has go, in the optics of many Lyme patients, an embodiment of the medical system's indifference, because he has long suggested that some chronic Lyme patients were incorrectly diagnosed in the start place. He has been shouted downwards at conferences and ambushed by people purporting to be journalistic interviewers. Scientists who disagree with him had however singled him out to me for his commitment to studying Lyme. I wanted to hear his perspective on the disease and on the fence after four decades of immersion in both.
While underscoring that medicine can exist humbling, and that Lyme disease is complex, Steere spoke with the calm air of someone setting a child straight. Emphasizing that in many people Lyme disease tin resolve on its own without antibiotics, he advisedly described a disease that in the United States oftentimes follows a specific progression of stages if untreated, beginning with an early rash and fever, then neurological symptoms, and culminating later in inflammatory arthritis. The joint inflammation can go along for months or even years after antibody treatment, but non, he believes, because the bacteria persist. His research on patients who have these standing arthritis symptoms has revealed one cause to be a genetic susceptibility to an ongoing inflammatory response. This discovery has led to effective treatment for the longer-term challenges of Lyme arthritis, using what are called disease-modifying anti-rheumatic agents.
Later I told him a piffling about my example, he struck a notation of similarly solicitous firmness. He told me that in his view, late-stage Lyme (which is what I had been diagnosed with) normally does non cause a lot of "systemic symptoms," such as the fatigue and brain fog I had experienced. "I want you lot to free yourself from the Lyme credo," he said. "You clearly were helped by antibiotic therapy. But I don't favor the idea that it was spirochetal infection. Of form, there are other infectious agents," he continued, noting that some of them trigger complex immune responses.
I left Steere'due south office unnerved, thinking that if I had met a doctor with some version of this view in 2014, I would never accept started doxycycline and gotten ameliorate. Could it really be that I had some condition other than Lyme that turned out to answer to antibiotics? He was an adept who had devoted his entire career to studying the mechanics of the illness; I was a patient who happens to be temperamentally both exacting and excitable, and scientifically curious—a layperson peckish bear witness.
That night I curled upwards with my reckoner in my hotel room and reread a 1976 New York Times article about the discovery of Lyme. New things struck me, in detail Steere's growing suspicion back so that bacteria couldn't be the crusade, considering this microorganism wasn't acting like a bacterium:
The bacterial infections that are known to crusade arthritis leave permanent joint impairment, and bacteria are easy to run into in torso fluids and piece of cake to grow in examination tubes. Every effort to culture leaner from fluids and tissues from the patients has failed.
Steere had moved on to a new possibility: "A virus is the most likely candidate," he told the Times. "Merely because we haven't found i withal doesn't mean it isn't in that location. We'll keep looking." When I recently wrote to ask him if he had been "fooled" past Lyme disease dorsum in the 1970s, he reminded me of how much he and others had learned, in just a few years, near this then-new infection. He went on to remind me that science tin can "atomic number 82 to one 'dead end' after some other. One needs to learn from these expressionless ends and continue trying."
"Anyone who says they really understand the pathophysiology of what's going on is oversimplifying to some degree," said Ramzi Asfour, a doctor and member of the Infectious Diseases Society of America with notably open views on Lyme disease, when I reached him on the phone in his Bay Expanse office. Asfour has found that a ane-size-fits-all approach to Lyme diagnosis and treatment is inadequate for most patients in his medical practice. Nosotros don't know enough yet about diseases that are characterized by abnormal activeness of the immune system, he emphasized. But, alongside the usual standardized protocols, they clearly call for the tactics of personalized medicine, considering the immune system is and then complex—and so individualized. For instance, autoimmune diseases tin be triggered by stressors that include trauma or infection. And standard lab reports don't always capture early stages of illness. Listening to patients is crucial.
"Being an infectious-disease doctor is usually pretty rewarding in the conventional sense," Asfour said. "The patient is in the ICU; you abound a bacteria, and you lot meet it; then you lot give them a magic pill. They get ameliorate and walk home. Information technology'south very satisfying." The experience of Lyme patients challenges that model. As the surgeon Atul Gawande in one case wrote of the medical profession, "Nothing is more threatening to who you think you are than a patient with a problem you cannot solve."
The less we understand about a affliction, as Susan Sontag argued years ago in Illness as Metaphor, the more nosotros tend to psychologize or stigmatize it. In the midst of the electric current contend over Lyme, I can't help thinking about other illnesses that mod medicine misunderstood for years. Multiple sclerosis was once chosen hysterical paralysis, and ulcers were considered "a affliction of tense, nervous persons who alive a strenuous and worrisome life," equally one mid-century medical manual put it, outlining a notion that remained common until the 1980s. In fact, ulcers are caused by bacteria—though when a researcher proposed as much in 1983, he was almost literally laughed out of a room of experts, who swore by the medical tenet that the tum was a sterile environment. Doctors now likewise know that not everyone with the leaner gets an ulcer—it'southward caused by a circuitous interplay of pathogen and host, of soil and seed, perhaps like mail service-treatment Lyme disease syndrome.
Information technology is truthful that Lyme illness has go a term that stands for more itself. If non an credo, it is a metonym for all tick-borne affliction, for embattled suffering, for the ways that medicine has fallen curt of its promised goal of doing no damage—in this case past dismissing and mocking suffering patients. Equally Wendy Adams of the Bay Area Lyme Foundation put information technology to me, "Nosotros now have incontrovertible data that says these people are legitimately sick." But because a symptom is common and subjective—every bit fatigue is—doesn't mean that a patient can't tell the difference between a normal version of information technology and a pathological one. Afterwards all, nosotros're able to distinguish betwixt the common cold and a case of the influenza. When I was very sick, I felt like a zombie—more important, I felt categorically different from myself. Past contrast, today I have aches and pains, and I'm tired, but I am more or less "me."
Recently, I chosen Richard Horowitz and several other Lyme experts to inquire them, once more, if they really thought it was likely that I had Lyme. "Meghan. Yous accept Lyme disease," Dr. H said. "You have had multiple Lyme-specific antibodies show upward on your tests. You had all the symptoms that led to a clinical diagnosis. And you got better when you took antibiotics." Others echoed his conclusion.
I live in uncertainties, as the poet John Keats put it while he was dying of an infection so thought to exist a disease of sensitive souls, which nosotros now know is tuberculosis. Just I am fairly sure of one thing. In a calendar week, or a month, or six months, I volition start feeling less well. My head will get foggier, my energy level will sink. When I wake in the morning time, I will accept a astringent headache. Precipitous electric shocks will showtime running along my legs and arms, for minutes, then hours, so days. My older son will stop eating his breakfast as I twitch in pain, and say, "What'southward wrong, Mommy?" And once again I will enquire Dr. H for antibiotics.
While writing this article, information technology happened. I took the antibiotics. I felt worse, and and so I felt dramatically ameliorate. In a few months, when I take stopped nursing my younger son, I will endeavour Dr. H'southward new anti-persister regimen. Consisting of 3 dissimilar drugs, including antibiotics used to care for persister bacteria institute in diseases similar TB and leprosy, it has put some of his nearly challenging patients into remission for nearly two years at present.
I tin't know for sure that I have Lyme disease. But to imagine that I might never have constitute the treatment that has saved my life in every sense—restoring its joy—terrifies me. I think ofttimes most patients who are less fortunate, whose disease, whatever it may exist, has gone unrecognized. 1 of the bitterest aspects of my disease has been this: Not only did I suffer from a disease, just I suffered at the hands of a medical establishment that discredited my testimony and—simply considering of my search for answers, and my own lived experiences—wrote me off as a loon. In the throes of disease, cut off from the life yous once lived, fearing that your future has been filched, what do you accept only the act of witness? This is what information technology is like. Please listen, and so that one day you might be able to help.
This commodity appears in the September 2022 print edition with the headline "Life With Lyme."
Source: https://www.theatlantic.com/magazine/archive/2019/09/life-with-lyme/594736/
0 Response to "If You Already Have Lyme Disease and Get Bit Again Does It Activate Faster/"
Postar um comentário